Drug intelligence / Profile preview

cefoperazone

Development stage
Phase 4
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Cefoperazone is a semisynthetic, broad-spectrum third-generation cephalosporin antibiotic. It is used to treat a variety of bacterial infections in different parts of the body, including the respiratory tract, abdomen, skin, and female genital tracts. Cefoperazone works by binding to specific penicillin-binding proteins (PBPs) inside the bacterial cell wall, inhibiting the final stage of bacterial cell wall synthesis and leading to cell lysis through autolytic enzymes. It is particularly notable for its activity against *Pseudomonas aeruginosa* and other Gram-negative bacteria that are often resistant to other cephalosporins. The drug contains an N-methylthiotetrazole (NMTT) side chain which can cause hypoprothrombinemia and disulfiram-like reactions with alcohol due to inhibition of vitamin K epoxide reductase and aldehyde dehydrogenase[1][2][4][5][6].

Brand names
CefobidSulperazon
Other names
cefoperazone sodium
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on cefoperazone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cefoperazone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call